“This Is Not (Just) Your Kid's ADHD”: A Life-Span Approach to the Treatment of Attention-Deficit/Hyperactivity Disorder

PsycCRITIQUES ◽  
2007 ◽  
Vol 52 (36) ◽  
Author(s):  
Joseph C. Blader
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Life Span ◽  
Attention Deficit ◽  
Hyperactivity Disorder

Co-morbidity in Adults with ADHD

CNS Spectrums ◽  
2008 ◽  
Vol 13 (S12) ◽  
pp. 12-15 ◽  
Author(s):  
Jeffrey H. Newcorn
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Substance Use ◽  
Life Span ◽  
Mood Disorders ◽  
Substance Use Disorder ◽  
Attention Deficit ◽  
Late Adolescence ◽  
Hyperactivity Disorder ◽  
Co Morbidity ◽  
Morbid Conditions

Attention-deficit/hyperactivity disorder (ADHD) is highly co-morbid across the life span. However, co-morbidity is not uniform across time; individual co-morbid conditions tend to occur at different times developmentally, with rates often reflecting lifetime occurrence (Slide 1). In addition to changes in the rates of co-morbidity, the nature of co-morbidity may also differ in late adolescence/adulthood, when co-morbid conditions can be especially impairing (eg, antisocial disorder, substance use disorder [SUD], more severe mood disorders).

Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition

2013 ◽  
Vol 25 (3) ◽  
pp. 231-243 ◽  
Author(s):  
Jose Martinez-Raga ◽  
Nestor Szerman ◽  
Carlos Knecht ◽  
Raquel de Alvaro
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Substance Use ◽  
Life Span ◽  
Attention Deficit ◽  
Psychosocial Assessment ◽  
Initial Assessment ◽  
Dually Diagnosed ◽  
Dual Disorders ◽  
Hyperactivity Disorder ◽  
Wide Range

Abstract A wide range of comorbid psychiatric disorders overlap with attention-deficit hyperactivity disorder (ADHD) across the life span. There is a robust and complex link between ADHD and substance use disorders (SUD). The aim of this report was to review the neurobiological and other vulnerability factors explaining the comorbidity of ADHD and an addictive disorder, as well as the key aspects of the assessment and diagnosis of dually diagnosed ADHD patients. A comprehensive and systematic search of relevant databases (PubMed, Embase, and PsychINFO) was conducted to identify studies published in peer-reviewed journals until July 31, 2012, with the aim of exploring the association of ADHD and SUD with postgraduate training and residency education. Across the life span, ADHD is associated with significant impairment and comorbidity. Data from epidemiological, clinical and epidemiological studies show a very solid link between ADHD and SUD. Therefore, it is very important to carefully and systematically assess for any substance use in patients with suspected ADHD coming to initial assessment, and vice versa. While there are various valid and reliable rating and screening scales, diagnosis cannot solely rely on any of the instruments available for both SUD and ADHD in adult patients with dual pathology. The most important and effective tool in the assessment of dually diagnosed patients with ADHD and SUD is a full and comprehensive clinical and psychosocial assessment. Hence, it is essential to actively incorporate training opportunities on the assessment, diagnosis, and management of adult ADHD and dually diagnosed ADHD patients during postgraduate education residency or specialist training.

Assessment of Attention-Deficit/Hyperactivity Disorder: An Evaluation of Six Published Rating Scales

2003 ◽  
Vol 32 (2) ◽  
pp. 241-262 ◽  
Author(s):  
Lisa Marie Angello ◽  
Robert J. Volpe ◽  
James C. DiPerna ◽  
Sammi P. Gureasko-Moore ◽  
David P. Gureasko-Moore ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Rating Scales ◽  
Hyperactivity Disorder
Sign in / Sign up

Export Citation Format

Share Document